Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema

• Status: Terminated
• Trial end date: 2015-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

This randomized clinical trial studies an investigational drug in preventing lymphedema in patients at high risk after undergoing axillary lymph node dissection. The study drug may prevent lymphedema in patients undergoing axillary lymph node dissection.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Treatments: Ketoprofen

Criteria

Inclusion Criteria:

• Axillary lymph node dissection within the preceding 12 months

Exclusion Criteria:

• Patients with active cancer

• Patients with lymphedema

• Infection or bleeding tendency

• Patients with medical contraindications to nonsteroidal anti-inflammatory drugs (NSAIDs), including history of allergies, know gastrointestinal intolerance

• Other serious systemic illness (e.g., renal failure, hepatic dysfunction, congestive heart failure, neurological or psychological impairment) that would impair the patients' ability to participate

• Persons not competent to consent

• Patients on aspirin therapy

• Minors (< 18 years of age)

• Pregnant and/or lactating women

• Males